The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neurofeedback Therapy Device Market Research Report 2025
Synopsis
Neurofeedback is a non-invasive method of monitoring and training your brain waves through electronic equipment (typically EEG devices) in order to evaluate your mind and body. Neurofeedback therapy helps you become a more well-rounded person equipped to tackle adversity as well as enhances your mental fitness so you can enjoy a balanced life and healthy relationships. Neurofeedback equipment plays a key role in optimizing your mental fitness.
Global Neurofeedback Therapy Device market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neurofeedback Therapy Device market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neurofeedback Therapy Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Interaxon
BrainMaster
Narbis
Neurosky
Sens.ai
Neurotech
Mendi
NeurOptimal
ANT Neuro
Neurogen
EEG Info
FocusCalm
NeuroSky
Thought Technology
Segment by Type
Electroencephalogram (EEG) Machines
Functional Magnetic Resonance Imaging (FMRI) Machines
Hemoencephalography (HEG) Devices
Segment by Application
Home
Professional Clinic
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neurofeedback Therapy Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Neurofeedback is a non-invasive method of monitoring and training your brain waves through electronic equipment (typically EEG devices) in order to evaluate your mind and body. Neurofeedback therapy helps you become a more well-rounded person equipped to tackle adversity as well as enhances your mental fitness so you can enjoy a balanced life and healthy relationships. Neurofeedback equipment plays a key role in optimizing your mental fitness.
Global Neurofeedback Therapy Device market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neurofeedback Therapy Device market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neurofeedback Therapy Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Interaxon
BrainMaster
Narbis
Neurosky
Sens.ai
Neurotech
Mendi
NeurOptimal
ANT Neuro
Neurogen
EEG Info
FocusCalm
NeuroSky
Thought Technology
Segment by Type
Electroencephalogram (EEG) Machines
Functional Magnetic Resonance Imaging (FMRI) Machines
Hemoencephalography (HEG) Devices
Segment by Application
Home
Professional Clinic
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neurofeedback Therapy Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Neurofeedback Therapy Device Market Overview
1.1 Product Overview and Scope of Neurofeedback Therapy Device
1.2 Neurofeedback Therapy Device Segment by Type
1.2.1 Global Neurofeedback Therapy Device Market Value Comparison by Type (2023-2029)
1.2.2 Electroencephalogram (EEG) Machines
1.2.3 Functional Magnetic Resonance Imaging (FMRI) Machines
1.2.4 Hemoencephalography (HEG) Devices
1.3 Neurofeedback Therapy Device Segment by Application
1.3.1 Global Neurofeedback Therapy Device Market Value by Application: (2023-2029)
1.3.2 Home
1.3.3 Professional Clinic
1.3.4 Hospital
1.4 Global Neurofeedback Therapy Device Market Size Estimates and Forecasts
1.4.1 Global Neurofeedback Therapy Device Revenue 2018-2029
1.4.2 Global Neurofeedback Therapy Device Sales 2018-2029
1.4.3 Global Neurofeedback Therapy Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurofeedback Therapy Device Market Competition by Manufacturers
2.1 Global Neurofeedback Therapy Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neurofeedback Therapy Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neurofeedback Therapy Device Average Price by Manufacturers (2018-2023)
2.4 Global Neurofeedback Therapy Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neurofeedback Therapy Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurofeedback Therapy Device, Product Type & Application
2.7 Neurofeedback Therapy Device Market Competitive Situation and Trends
2.7.1 Neurofeedback Therapy Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurofeedback Therapy Device Players Market Share by Revenue
2.7.3 Global Neurofeedback Therapy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurofeedback Therapy Device Retrospective Market Scenario by Region
3.1 Global Neurofeedback Therapy Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurofeedback Therapy Device Global Neurofeedback Therapy Device Sales by Region: 2018-2029
3.2.1 Global Neurofeedback Therapy Device Sales by Region: 2018-2023
3.2.2 Global Neurofeedback Therapy Device Sales by Region: 2024-2029
3.3 Global Neurofeedback Therapy Device Global Neurofeedback Therapy Device Revenue by Region: 2018-2029
3.3.1 Global Neurofeedback Therapy Device Revenue by Region: 2018-2023
3.3.2 Global Neurofeedback Therapy Device Revenue by Region: 2024-2029
3.4 North America Neurofeedback Therapy Device Market Facts & Figures by Country
3.4.1 North America Neurofeedback Therapy Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurofeedback Therapy Device Sales by Country (2018-2029)
3.4.3 North America Neurofeedback Therapy Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurofeedback Therapy Device Market Facts & Figures by Country
3.5.1 Europe Neurofeedback Therapy Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurofeedback Therapy Device Sales by Country (2018-2029)
3.5.3 Europe Neurofeedback Therapy Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurofeedback Therapy Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neurofeedback Therapy Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurofeedback Therapy Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurofeedback Therapy Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurofeedback Therapy Device Market Facts & Figures by Country
3.7.1 Latin America Neurofeedback Therapy Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurofeedback Therapy Device Sales by Country (2018-2029)
3.7.3 Latin America Neurofeedback Therapy Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurofeedback Therapy Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurofeedback Therapy Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurofeedback Therapy Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurofeedback Therapy Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurofeedback Therapy Device Sales by Type (2018-2029)
4.1.1 Global Neurofeedback Therapy Device Sales by Type (2018-2023)
4.1.2 Global Neurofeedback Therapy Device Sales by Type (2024-2029)
4.1.3 Global Neurofeedback Therapy Device Sales Market Share by Type (2018-2029)
4.2 Global Neurofeedback Therapy Device Revenue by Type (2018-2029)
4.2.1 Global Neurofeedback Therapy Device Revenue by Type (2018-2023)
4.2.2 Global Neurofeedback Therapy Device Revenue by Type (2024-2029)
4.2.3 Global Neurofeedback Therapy Device Revenue Market Share by Type (2018-2029)
4.3 Global Neurofeedback Therapy Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurofeedback Therapy Device Sales by Application (2018-2029)
5.1.1 Global Neurofeedback Therapy Device Sales by Application (2018-2023)
5.1.2 Global Neurofeedback Therapy Device Sales by Application (2024-2029)
5.1.3 Global Neurofeedback Therapy Device Sales Market Share by Application (2018-2029)
5.2 Global Neurofeedback Therapy Device Revenue by Application (2018-2029)
5.2.1 Global Neurofeedback Therapy Device Revenue by Application (2018-2023)
5.2.2 Global Neurofeedback Therapy Device Revenue by Application (2024-2029)
5.2.3 Global Neurofeedback Therapy Device Revenue Market Share by Application (2018-2029)
5.3 Global Neurofeedback Therapy Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Interaxon
6.1.1 Interaxon Corporation Information
6.1.2 Interaxon Description and Business Overview
6.1.3 Interaxon Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Interaxon Neurofeedback Therapy Device Product Portfolio
6.1.5 Interaxon Recent Developments/Updates
6.2 BrainMaster
6.2.1 BrainMaster Corporation Information
6.2.2 BrainMaster Description and Business Overview
6.2.3 BrainMaster Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BrainMaster Neurofeedback Therapy Device Product Portfolio
6.2.5 BrainMaster Recent Developments/Updates
6.3 Narbis
6.3.1 Narbis Corporation Information
6.3.2 Narbis Description and Business Overview
6.3.3 Narbis Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Narbis Neurofeedback Therapy Device Product Portfolio
6.3.5 Narbis Recent Developments/Updates
6.4 Neurosky
6.4.1 Neurosky Corporation Information
6.4.2 Neurosky Description and Business Overview
6.4.3 Neurosky Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Neurosky Neurofeedback Therapy Device Product Portfolio
6.4.5 Neurosky Recent Developments/Updates
6.5 Sens.ai
6.5.1 Sens.ai Corporation Information
6.5.2 Sens.ai Description and Business Overview
6.5.3 Sens.ai Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sens.ai Neurofeedback Therapy Device Product Portfolio
6.5.5 Sens.ai Recent Developments/Updates
6.6 Neurotech
6.6.1 Neurotech Corporation Information
6.6.2 Neurotech Description and Business Overview
6.6.3 Neurotech Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Neurotech Neurofeedback Therapy Device Product Portfolio
6.6.5 Neurotech Recent Developments/Updates
6.7 Mendi
6.6.1 Mendi Corporation Information
6.6.2 Mendi Description and Business Overview
6.6.3 Mendi Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mendi Neurofeedback Therapy Device Product Portfolio
6.7.5 Mendi Recent Developments/Updates
6.8 NeurOptimal
6.8.1 NeurOptimal Corporation Information
6.8.2 NeurOptimal Description and Business Overview
6.8.3 NeurOptimal Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 NeurOptimal Neurofeedback Therapy Device Product Portfolio
6.8.5 NeurOptimal Recent Developments/Updates
6.9 ANT Neuro
6.9.1 ANT Neuro Corporation Information
6.9.2 ANT Neuro Description and Business Overview
6.9.3 ANT Neuro Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ANT Neuro Neurofeedback Therapy Device Product Portfolio
6.9.5 ANT Neuro Recent Developments/Updates
6.10 Neurogen
6.10.1 Neurogen Corporation Information
6.10.2 Neurogen Description and Business Overview
6.10.3 Neurogen Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neurogen Neurofeedback Therapy Device Product Portfolio
6.10.5 Neurogen Recent Developments/Updates
6.11 EEG Info
6.11.1 EEG Info Corporation Information
6.11.2 EEG Info Neurofeedback Therapy Device Description and Business Overview
6.11.3 EEG Info Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 EEG Info Neurofeedback Therapy Device Product Portfolio
6.11.5 EEG Info Recent Developments/Updates
6.12 FocusCalm
6.12.1 FocusCalm Corporation Information
6.12.2 FocusCalm Neurofeedback Therapy Device Description and Business Overview
6.12.3 FocusCalm Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 FocusCalm Neurofeedback Therapy Device Product Portfolio
6.12.5 FocusCalm Recent Developments/Updates
6.13 NeuroSky
6.13.1 NeuroSky Corporation Information
6.13.2 NeuroSky Neurofeedback Therapy Device Description and Business Overview
6.13.3 NeuroSky Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 NeuroSky Neurofeedback Therapy Device Product Portfolio
6.13.5 NeuroSky Recent Developments/Updates
6.14 Thought Technology
6.14.1 Thought Technology Corporation Information
6.14.2 Thought Technology Neurofeedback Therapy Device Description and Business Overview
6.14.3 Thought Technology Neurofeedback Therapy Device Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Thought Technology Neurofeedback Therapy Device Product Portfolio
6.14.5 Thought Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurofeedback Therapy Device Industry Chain Analysis
7.2 Neurofeedback Therapy Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurofeedback Therapy Device Production Mode & Process
7.4 Neurofeedback Therapy Device Sales and Marketing
7.4.1 Neurofeedback Therapy Device Sales Channels
7.4.2 Neurofeedback Therapy Device Distributors
7.5 Neurofeedback Therapy Device Customers
8 Neurofeedback Therapy Device Market Dynamics
8.1 Neurofeedback Therapy Device Industry Trends
8.2 Neurofeedback Therapy Device Market Drivers
8.3 Neurofeedback Therapy Device Market Challenges
8.4 Neurofeedback Therapy Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
